|
|
|
|
|
|
|
|
|
|
Note: Dr Vergote is one of Europe's top gynecologic cancer researchers; journal correspondence=pay-per-view ($$$)
Neoadjuvant chemotherapy in advanced ovarian cancer: What kind of evidence is needed to convince US gynaecological oncologists?
Vergote I, Amant F, Leunen K.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.